Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]
News [2698]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Prof Alex Eggermont - Paris-Sud University, Paris, France
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab. ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Doubled survival in metastatic lung cancer with combination therapy
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Combined immuno-chemotherapy improves survival and responses in metastatic lung...
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Results from CheckMate-227 : Immune combination reaches PFS endpoint
Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 : Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
6-factor prognostic model for patients with advanced urothelial carcinoma
Dr Gregory Pond - McMaster University, Hamilton, Ontario
6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )
9 Feb 2018
Comment: Urothelial cancer research from ASCO GU 2018
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...
Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )
9 Feb 2018
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...
Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )
9 Feb 2018
Updates on non-metastatic castration-resistant prostate cancer
Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small
Updates on non-metastatic castration-resistant prostate cancer ( Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small )
8 Feb 2018
Updates in metastatic prostate cancer
Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet
Updates in metastatic prostate cancer ( Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet )
8 Feb 2018
Neoadjuvant and adjuvant therapy in triple negative breast cancer
Prof Banu Arun - MD Anderson Center, Houston, USA
Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation